Cargando…

Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey

BACKGROUND: As vaccination against coronavirus disase-19 (COVID-19) evolves, hesitancy has become a problematic issue that has gradually spread worldwide. The main reason for vaccine hesitancy is uncertainties about vaccine side effects. AIMS: To evaluate the safety of an inactivated COVID-19 vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Baydar, Oya, Özen, Şennur, Öztürk Şahin, Burcu, Köktürk, Nurdan, Kitapçı, Mehmet Tevfik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136550/
https://www.ncbi.nlm.nih.gov/pubmed/35380034
http://dx.doi.org/10.4274/balkanmedj.galenos.2022.2021-11-25
_version_ 1784714207661391872
author Baydar, Oya
Özen, Şennur
Öztürk Şahin, Burcu
Köktürk, Nurdan
Kitapçı, Mehmet Tevfik
author_facet Baydar, Oya
Özen, Şennur
Öztürk Şahin, Burcu
Köktürk, Nurdan
Kitapçı, Mehmet Tevfik
author_sort Baydar, Oya
collection PubMed
description BACKGROUND: As vaccination against coronavirus disase-19 (COVID-19) evolves, hesitancy has become a problematic issue that has gradually spread worldwide. The main reason for vaccine hesitancy is uncertainties about vaccine side effects. AIMS: To evaluate the safety of an inactivated COVID-19 vaccine, CoronaVac, and determine the risk factors of emergence of side effects. STUDY DESIGN: Cross-sectional study. METHODS: An online questionnaire was administered via the internet to healthcare workers who received one or two doses of CoronaVac. The online survey consisted of three sections detailing sociodemographic data, COVID-19 history, and post-vaccine side effects. Side effects that occurred in the period starting from immediately after the first vaccination to the end of the 14th day after the second vaccination were recorded. RESULTS: A total of 1628 healthcare workers responded to the online survey. Of these, 24.3% had a side effect either after the first or second dose of CoronaVac. Redness and/or pain at the inoculation site, headache, muscle and joint pains, palpitations, and dizziness were the most common side effects. Female sex, age <50 years, and thyroid disorder in the pre-vaccine period were found to be risk factors for the emergence of side effects. Blood pressure control could not be achieved in 2.2% of participants despite medication use, and permanent medication was needed in 2.5% of participants for blood pressure control. CONCLUSION: Almost a quarter of healthcare workers have at least one side effect after the first or second dose of CoronaVac. Female gender, age <50 years, and thyroid disorder appear to be risk factors for the occurrence of side effects.
format Online
Article
Text
id pubmed-9136550
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-91365502022-06-08 Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey Baydar, Oya Özen, Şennur Öztürk Şahin, Burcu Köktürk, Nurdan Kitapçı, Mehmet Tevfik Balkan Med J Original Article BACKGROUND: As vaccination against coronavirus disase-19 (COVID-19) evolves, hesitancy has become a problematic issue that has gradually spread worldwide. The main reason for vaccine hesitancy is uncertainties about vaccine side effects. AIMS: To evaluate the safety of an inactivated COVID-19 vaccine, CoronaVac, and determine the risk factors of emergence of side effects. STUDY DESIGN: Cross-sectional study. METHODS: An online questionnaire was administered via the internet to healthcare workers who received one or two doses of CoronaVac. The online survey consisted of three sections detailing sociodemographic data, COVID-19 history, and post-vaccine side effects. Side effects that occurred in the period starting from immediately after the first vaccination to the end of the 14th day after the second vaccination were recorded. RESULTS: A total of 1628 healthcare workers responded to the online survey. Of these, 24.3% had a side effect either after the first or second dose of CoronaVac. Redness and/or pain at the inoculation site, headache, muscle and joint pains, palpitations, and dizziness were the most common side effects. Female sex, age <50 years, and thyroid disorder in the pre-vaccine period were found to be risk factors for the emergence of side effects. Blood pressure control could not be achieved in 2.2% of participants despite medication use, and permanent medication was needed in 2.5% of participants for blood pressure control. CONCLUSION: Almost a quarter of healthcare workers have at least one side effect after the first or second dose of CoronaVac. Female gender, age <50 years, and thyroid disorder appear to be risk factors for the occurrence of side effects. Galenos Publishing 2022-05-24 /pmc/articles/PMC9136550/ /pubmed/35380034 http://dx.doi.org/10.4274/balkanmedj.galenos.2022.2021-11-25 Text en ©Copyright 2022 by Trakya University Faculty of Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Balkan Medical Journal published by Galenos Publishing House.
spellingShingle Original Article
Baydar, Oya
Özen, Şennur
Öztürk Şahin, Burcu
Köktürk, Nurdan
Kitapçı, Mehmet Tevfik
Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey
title Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey
title_full Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey
title_fullStr Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey
title_full_unstemmed Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey
title_short Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey
title_sort safety of an inactivated sars-cov-2 vaccine among healthcare workers in turkey: an online survey
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136550/
https://www.ncbi.nlm.nih.gov/pubmed/35380034
http://dx.doi.org/10.4274/balkanmedj.galenos.2022.2021-11-25
work_keys_str_mv AT baydaroya safetyofaninactivatedsarscov2vaccineamonghealthcareworkersinturkeyanonlinesurvey
AT ozensennur safetyofaninactivatedsarscov2vaccineamonghealthcareworkersinturkeyanonlinesurvey
AT ozturksahinburcu safetyofaninactivatedsarscov2vaccineamonghealthcareworkersinturkeyanonlinesurvey
AT kokturknurdan safetyofaninactivatedsarscov2vaccineamonghealthcareworkersinturkeyanonlinesurvey
AT kitapcımehmettevfik safetyofaninactivatedsarscov2vaccineamonghealthcareworkersinturkeyanonlinesurvey